(REPX) Riley Exploration Permian - Overview
Stock: Oil, Natural Gas, Natural Gas Liquids
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.87% |
| Yield on Cost 5y | 6.82% |
| Yield CAGR 5y | 15.35% |
| Payout Consistency | 100.0% |
| Payout Ratio | 40.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 46.3% |
| Relative Tail Risk | -5.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -29.77 |
| Character TTM | |
|---|---|
| Beta | 1.377 |
| Beta Downside | 1.835 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.79% |
| CAGR/Max DD | 0.02 |
Description: REPX Riley Exploration Permian December 26, 2025
Riley Exploration Permian, Inc. (NYSE MKT: REPX) is an independent upstream firm that acquires, explores, develops, and produces crude oil, natural gas, and natural gas liquids (NGLs) primarily in Yoakum County, Texas, and Eddy County, New Mexico. The company is headquartered in Oklahoma City and trades as a common stock under the GICS sub-industry “Oil & Gas Refining & Marketing.”
Key operational metrics (as of Q2 2024) show a daily production rate of roughly 1,200 boe/d, with a weighted average realized price of $78 per boe and an estimated all-in cash breakeven of $45 per boe, reflecting the low-cost nature of its contiguous acreage. The Permian Basin’s recent 4 % YoY output growth and sustained drilling activity, driven by robust demand for NGLs in the petrochemical sector, remain primary macro drivers for REPX’s upside potential.
For a deeper quantitative assessment, the ValueRay platform offers a detailed, model-driven analysis of REPX’s financials and risk profile.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 86.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -4.29 > 1.0 |
| NWC/Revenue: -12.06% < 20% (prev -7.84%; Δ -4.22% < -1%) |
| CFO/TA 0.18 > 3% & CFO 214.0m > Net Income 86.4m |
| Net Debt (358.5m) to EBITDA (227.8m): 1.57 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.3m) vs 12m ago 0.25% < -2% |
| Gross Margin: 57.10% > 18% (prev 0.62%; Δ 5648 % > 0.5%) |
| Asset Turnover: 36.31% > 50% (prev 40.82%; Δ -4.51% > 0%) |
| Interest Coverage Ratio: 4.50 > 6 (EBITDA TTM 227.8m / Interest Expense TTM 31.7m) |
Altman Z'' 1.72
| A: -0.04 (Total Current Assets 79.4m - Total Current Liabilities 127.3m) / Total Assets 1.19b |
| B: 0.21 (Retained Earnings 250.9m / Total Assets 1.19b) |
| C: 0.13 (EBIT TTM 142.8m / Avg Total Assets 1.09b) |
| D: 0.40 (Book Value of Equity 250.9m / Total Liabilities 624.8m) |
| Altman-Z'' Score: 1.72 = BBB |
Beneish M -2.84
| DSRI: 1.03 (Receivables 41.1m/41.0m, Revenue 397.4m/407.3m) |
| GMI: 1.09 (GM 57.10% / 62.06%) |
| AQI: 1.36 (AQ_t 0.04 / AQ_t-1 0.03) |
| SGI: 0.98 (Revenue 397.4m / 407.3m) |
| TATA: -0.11 (NI 86.4m - CFO 214.0m) / TA 1.19b) |
| Beneish M-Score: -2.84 (Cap -4..+1) = A |
What is the price of REPX shares?
Over the past week, the price has changed by +1.64%, over one month by +16.79%, over three months by +17.60% and over the past year by -6.22%.
Is REPX a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the REPX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46 | 61.3% |
| Analysts Target Price | 46 | 61.3% |
| ValueRay Target Price | 30.4 | 6.6% |
REPX Fundamental Data Overview February 03, 2026
P/E Forward = 8.9606
P/S = 1.5558
P/B = 1.0878
Revenue TTM = 397.4m USD
EBIT TTM = 142.8m USD
EBITDA TTM = 227.8m USD
Long Term Debt = 347.0m USD (from longTermDebt, last quarter)
Short Term Debt = 27.9m USD (from shortTermDebt, last quarter)
Debt = 374.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 358.5m USD (from netDebt column, last quarter)
Enterprise Value = 976.8m USD (618.3m + Debt 374.9m - CCE 16.5m)
Interest Coverage Ratio = 4.50 (Ebit TTM 142.8m / Interest Expense TTM 31.7m)
EV/FCF = 9.60x (Enterprise Value 976.8m / FCF TTM 101.7m)
FCF Yield = 10.41% (FCF TTM 101.7m / Enterprise Value 976.8m)
FCF Margin = 25.60% (FCF TTM 101.7m / Revenue TTM 397.4m)
Net Margin = 21.73% (Net Income TTM 86.4m / Revenue TTM 397.4m)
Gross Margin = 57.10% ((Revenue TTM 397.4m - Cost of Revenue TTM 170.5m) / Revenue TTM)
Gross Margin QoQ = 67.10% (prev 47.81%)
Tobins Q-Ratio = 0.82 (Enterprise Value 976.8m / Total Assets 1.19b)
Interest Expense / Debt = 2.61% (Interest Expense 9.80m / Debt 374.9m)
Taxrate = 22.77% (4.82m / 21.2m)
NOPAT = 110.3m (EBIT 142.8m * (1 - 22.77%))
Current Ratio = 0.62 (Total Current Assets 79.4m / Total Current Liabilities 127.3m)
Debt / Equity = 0.66 (Debt 374.9m / totalStockholderEquity, last quarter 566.5m)
Debt / EBITDA = 1.57 (Net Debt 358.5m / EBITDA 227.8m)
Debt / FCF = 3.52 (Net Debt 358.5m / FCF TTM 101.7m)
Total Stockholder Equity = 541.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.89% (Net Income 86.4m / Total Assets 1.19b)
RoE = 15.95% (Net Income TTM 86.4m / Total Stockholder Equity 541.6m)
RoCE = 16.07% (EBIT 142.8m / Capital Employed (Equity 541.6m + L.T.Debt 347.0m))
RoIC = 13.26% (NOPAT 110.3m / Invested Capital 831.9m)
WACC = 7.60% (E(618.3m)/V(993.2m) * Re(10.99%) + D(374.9m)/V(993.2m) * Rd(2.61%) * (1-Tc(0.23)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.08%
[DCF Debug] Terminal Value 82.56% ; FCFF base≈112.2m ; Y1≈138.4m ; Y5≈235.8m
Fair Price DCF = 180.8 (EV 4.33b - Net Debt 358.5m = Equity 3.97b / Shares 22.0m; r=7.60% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -5.68 | EPS CAGR: 37.63% | SUE: -2.05 | # QB: 0
Revenue Correlation: 69.95 | Revenue CAGR: 18.11% | SUE: 0.63 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.76 | Chg30d=+0.020 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=4.54 | Chg30d=+0.005 | Revisions Net=+1 | Growth EPS=-0.8% | Growth Revenue=+11.1%